Growth of Edwards Lifesciences requires $100 million campus renovation
19 Sep 2017
Edwards Lifesciences, designers and manufacturers of the Sapien Transcatheter Heart Valve - the first aortic valve approved in the U.S. that doesn’t require open-heart surgery - have recently completed a $100 million renovation of their global headquarters in Irvine.
Edwards Lifesciences, the innovative medical device maker, have recently complete a $100 million renovation of their global headquarters.
The expansion of their Irvine site has proved necessary thanks to company growth following the success of their Sapien Transcatheter Heart Valve, released six years ago. The Sapien, which is now in its third generation, is used to treat intermediate and greater-risk patients who are suffering from severe, symptomatic aortic stenosis.
It is the first aortic valve to be approved in the U.S. that doesn’t require open-heart surgery. Success has seen Edwards grow locally in Irvine from 2,500 to 3,700 employees and globally they now employ nearly 12,000 staff.
Completion of the work was celebrated at this summer’s opening of their Starr Atrium. This is a 25,000-square- foot space with wooden stair seating, sofas, a coffee stand and even a 400-inch TV screen designed to host all-employee meetings and to serve as a collaborative workspace. They also opened a four- story office building with a cafeteria last year and added manufacturing and open green spaces on the 15-acre campus at McGaw and Red Hill avenues.